Clinical Trials Browser

Unknown × OTHER × Patient Reported Outcome Measures × Clear all

Breast Neoplasm Female

NCT04663100 2023-12-04

Oral Adherence in Hematological Oncology Agents and Impact on Comorbid Therapy Adherence

LymphoidMyeloidOther hematologic neoplasmOther neoplasmPlasma cell

Multiple Chronic Conditions, Leukemia, Multiple Myeloma, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Hematologic Neoplasms

NCT04146064 2023-06-05

Breathomics as Predictive Biomarker for Checkpoint Inhibitor Response

Unknown

425 enrolled

DermatologicGenitourinaryHead & Neck

Carcinoma, Transitional Cell, Head and Neck Neoplasms, Kidney Neoplasms, Melanoma

NCT04292353 2021-05-05

WP-12

Unknown

67 enrolled

CNS

Brain Neoplasms, Radiation Injuries, Cognitive Dysfunction

NCT02304614 2020-10-22

3DBCT

Unknown

346 enrolled

Breast

Breast Neoplasms

NCT02288078 2014-11-13

Oral Steroids for Regorafenib-induced Fatigue/Malaise in Unresectable mCRC (KSCC1402/HGCSG1402)

Phase 2 Unknown

74 enrolled

Gastrointestinal

Fatigue, Rectal Neoplasms

Clinical Trials

PRO

Oral Adherence in Hematological Oncology Agents and Impact on Comorbid Therapy Adherence

Breathomics as Predictive Biomarker for Checkpoint Inhibitor Response

WP-12

3DBCT

Oral Steroids for Regorafenib-induced Fatigue/Malaise in Unresectable mCRC (KSCC1402/HGCSG1402)